Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome

Author： Hill J.M. Ades A.M. McCune S.K. Sahir N. Moody E.M. Abebe D.T. Crnic L.S. Brenneman D.E.

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.183, Iss.1, 2003-09, pp. : 56-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression and fine mapping of murine vasoactive intestinal peptide receptor 1

By Karacay Bahri O’Dorisio M.Sue Kasow Kim Hollenback Clay Krahe Ralf

Journal of Molecular Neuroscience, Vol. 17, Iss. 3, 2001-12 ,pp. : 311-324

Humana Press, Inc

Access to resources Recommend Favorite

A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells

By Sharma Anita Walters James Gozes Yehoshua Fridkin Mati Brennman Douglas Gozes Illana Moody Terry

Journal of Molecular Neuroscience, Vol. 17, Iss. 3, 2001-12 ,pp. : 331-339

Humana Press, Inc

Access to resources Recommend Favorite

Enlarged Brain Ventricles and Impaired Neurogenesis in the Ts1Cje and Ts2Cje Mouse Models of Down Syndrome

By Ishihara Keiichi Amano Kenji Takaki Eiichi Shimohata Atsushi Sago Haruhiko J. Epstein Charles Yamakawa Kazuhiro

Cerebral Cortex, Vol. 20, Iss. 5, 2010-05 ,pp. : 1131-1143

Oxford University Press

Access to resources Recommend Favorite

Does ceruloplasmin differential express in the brain of Ts65Dn: a mouse mode of Down syndrome?

By Yu Bin Kong Jing Xing Baoling Zhu Ziqiang Zhang Bin Wang Qiu-wei Shao Shi-he

Neurological Sciences, Vol. 35, Iss. 4, 2014-04 ,pp. : 589-593

Springer Publishing Company

Access to resources Recommend Favorite

Alterations of Neocortical Pyramidal Cell Phenotype in the Ts65Dn Mouse Model of Down Syndrome: Effects of Environmental Enrichment

By Dierssen M.

Cerebral Cortex, Vol. 13, Iss. 7, 2003-07 ,pp. : 758-764

Oxford University Press

Access to resources Recommend Favorite